dbACP: A Comprehensive Database of Anti-Cancer Peptides

10 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp06645 Mel-C GIGAVLKVLTTGLPALISWIKRKRQQC Synthetic analogue Plasma memberane pore formation MTT assay HeLa Cervical Cancer IC50 = 50.72 µg/mL
dbacp06646 Mel-C GIGAVLKVLTTGLPALISWIKRKRQQC Synthetic analogue Plasma memberane pore formation MTT assay C-33A Cervical Cancer IC50 = 58.63 µg/mL
dbacp06647 Mel-C GIGAVLKVLTTGLPALISWIKRKRQQC Synthetic analogue Plasma memberane pore formation MTT assay MCF-7 Breast Cancer IC50 = 160.62 µg/mL
dbacp06648 MC–FA GIGAVLKVLTTGLPALISWIKRKRQQC Synthetic analogue Plasma memberane pore formation MTT assay HeLa Cervical Cancer IC50 = 66.43 µg/mL
dbacp06649 MC–FA GIGAVLKVLTTGLPALISWIKRKRQQC Synthetic analogue Plasma memberane pore formation MTT assay C-33A Cervical Cancer IC50 = 35.22 µg/ mL
dbacp06650 MC–FA GIGAVLKVLTTGLPALISWIKRKRQQC Synthetic analogue Plasma memberane pore formation MTT assay MCF-7 Breast Cancer IC50 = 12.63 µg/mL
dbacp07339 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay A-549 Lung Cancer IC50 = 4.5 µM
dbacp07340 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay CT-26 Colorectal Cancer IC50 = 2.2 µM
dbacp07341 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay MDA-MB-435 WT Breast Cancer IC50 = 3.5 µM
dbacp07342 D-melittin gigavlkvlttglpaliswikrkrqqc Synthetic pH-triggered release, membrane lysis, immunogenic death MTS assay MDA-MB-435 DOX-R Breast Cancer IC50 = 3.4 µM